Optimizing Guideline-Directed Medical Therapy During Hospitalization Improves Prognosis in Patients With Worsening Heart Failure Requiring Readmissions-Reference-Cited by-同舟云学术

Optimizing Guideline-Directed Medical Therapy During Hospitalization Improves Prognosis in Patients With Worsening Heart Failure Requiring Readmissions

Published:2024-08-23 Issue:9 Volume:88 Page:1416-1424
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Matsukawa Ryuichi¹,Kabu Keisuke¹,Koga Eiichi¹,Hara Ayano¹,Kisanuki Hiroshi¹,Sada Masashi¹,Okabe Kousuke¹,Okahara Arihide¹,Tokutome Masaki¹,Kawai Shunsuke¹,Ogawa Kiyohiro¹,Matsuura Hirohide¹,Mukai Yasushi¹

Affiliation:

1. Department of Cardiology, Japanese Red Cross Fukuoka Hospital

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circj/88/9/88_CJ-24-0265/_pdf

Reference31 articles.

1. 1. Authors/Task Force Members; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022; 24: 4–131.

2. 2. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e876–e894.

3. 3. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, et al. JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure. J Card Fail 2021; 27: 1404–1444.

4. 4. Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Ferreira JP, Zannad F, et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: A comparative analysis of three randomised controlled trials. Lancet 2020; 396: 121–128.

5. 5. Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P, et al. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. JACC Heart Fail 2022; 10: 73–84.